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LOBECTOMY--VIDEO-ASSISTED 
THORACIC SURGERY 
VERSUS MUSCLE-SPARING 
THORACOTOMY 
A randomized trial 
Video-assisted thoracic surgery has been adopted by some thoracic surgeons as the 
preferred approach over thoracotomy for many benign and malignant diseases of 
the chest. However, little concrete vidence xists to support his technique as the 
superior approach. T is randomized study was carried out to define the advantages 
of video-assisted lobeetomy over muscle-sparing thoracotomy and lobectomy. Sixty- 
one patients with presumed clinical stage I non-small-cell lung cancer were entered 
into the study. Each patient was randomized to muscle-sparing thoracotomy and 
lobectomy or video-assisted lobectomy. Six patients were excluded from the study 
either because final pathologic results revealed nonmalignant disease (3 patients) or 
because an attempted video-assisted lobectomy was converted to a thoracotomy. 
This left 30 patients in the thoracotomy group and 25 patients in the video-assisted 
group. No significant ditferences existed between the two groups in operating time, 
intraoperative blood loss, duration of chest ube drainage, or length of hospital stay. 
Significantly more postoperative complications occurred in the thoracotomy group 
(t7 < 0.5), the majority of which were prolonged air leaks. Return to work time was 
not an issue because the majority of the patients were either retired or not working 
at the time of the operation. Only three patients had persistent postthoracotomy 
pain (thoracotomy, n = 2; video-assisted lobectomy, n = 1). We conclude that 
video-assisted lobectomy was not associated with a significant decrease in duration 
of chest tube drainage, length of hospital stay, postthoracotomy pain, or, in this 
group of patients, a faster recovery time and return to work. Video-assisted 
lobectomy continues to expose the patient o the risk of a major pulmonary resection 
being done in an essentially closed chest. These results illustrate the need for critical 
evaluation of video-assisted thoracic surgery before the procedure is accepted as  a 
superior approach based on presumed and thus far unproved advantages. (J
THORAC CARDIOVASC SURG 1995;109:997-1002) 
Thomas J. Kirby, MD a (by invitation), Michael J. Mack, MD b (by invitation), 
Rodney J. Landreneau, MD ° (by invitation), and Thomas W. Rice, MD, a 
Cleveland, Ohio, Dallas, Tex., and Pittsburgh, Pa. 
T he recent introduction of video-assisted thoracic surgery (VATS) has allowed many procedures 
that previously required a thoracotomy to be per- 
formed by way of this "minimally invasive ap- 
proach." Lung biopsy, wedge excision of pulmonary 
nodules, blebectomy and bullectomy, thymectomy, 
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and resection of mediastinal tumors have now all 
been successfully and safely accomplished by a 
VATS approach. 1-7 However, little or no evidence 
exists that VATS offers these patients significant 
advantages over more "conventional" and time-- 
proven approaches. Proponents of VATS have as- 
sumed that this less-invasive technique represents 
an improved approach with advantages for both the 
surgeon and patient. In some instances VATS rep- 
resents a more- and not a less-invasive and compli- 
cated procedure, necessitating single lung ventila- 
tion, multiple thoracoports, and complex, expensive, 
and often inadequate instruments. Also, both the 
patient and the surgeon are interested in long-term 
control of disease, particularly malignant disease, 
and not short-term goals such as pain control and 
length of hospital stay?' 9 Last, because the majority 
of general thoracic surgical proeedures involve ma- 
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Table I. Demography of 61 patients randomized 
into either MST or VATS lobectomy 
MS T VA TS 
Patients 31 30 
Mean age (yr) 62 -+ 12 58 -+ 9 
Male/female 14:17 12:18 
jor resections of either the lung or esophagus, VATS 
will have to be shown to be advantageous in these 
areas if it is ever to play more than a minor role in 
thoracic surgery. 
The initial reports of VATS pulmonary lobectomy 
for malignant disease described the technique and 
demonstrated that a major pulmonary reseetion 
could be safely performed by way of a minimally 
invasive approach. 1°-12 There are many potential 
advantages of VATS lobectomy over a standard 
thoracotomy and resection, but these generally as- 
sumed advantages have yet to be conclusively dem- 
onstrated. Therefore we designed a randomized 
trial to compare VATS lobectomy with muscle- 
sparing thoracotomy (MST) and lobectomy in an 
attempt o define the specific advantages or disad- 
vantages of these two approaches. 
Patients and methods 
Between October 1991 and December 1993, 61 patients 
with confirmed or what preoperatively was thought to be 
stage I (Tl NO, T2 NO) non-small-cell ung carcinoma 
were randomized into either MST lobectomy or VATS 
lobectomy (Table I). Preoperative studies included hemo- 
gram, SMA-16, electrocardiogram, computed tomo- 
graphic scan of the chest, arterial blood gases, and pul- 
monary function testing. In most instances patients also 
underwent investigation to rule out extrathoracic spread 
of disease including a bone scan and computed tomo- 
graphic scan of the head and abdomen. Each patient was 
believed to be a good operative risk for a pulmonary 
lobectomy. 
At the time of the operation, the patients were random- 
ized to undergo either of two procedures: lobectomy 
through an MST (31 patients) or lobectomy by means of 
VATS (30 patients). Because of the known inaccuracy of 
computed tomographic s an in staging mediastinal lymph 
nodes, 52 patients (Table II) also had a staging mediasti- 
noscopy and, where indicated, anterior mediastinotomy in 
an attempt to ensure uniform pathologic staging of the 
two groups. 13-16 None of these 52 patients had N2 disease. 
Patients randomized to the MST group had a posterio- 
lateral thoracotomy performed through the fourth or fifth 
intercostal space, preserving both the serratus anterior 
and latissimus dorsi muscles. The mediastinum was then 
carefully reevaluated and restaged by biopsy of additional 
mediastinal lymph nodes and frozen section analysis. The 
average total number of lymph nodes sampled in each 
group is shown in Table II. A complete and potentially 
Table II. Number of mediastinoscopies p rformed 
in each group and average total number of lymph 
nodes from which biopsies were taken at 
mediastinoscopy and thoracotomy 
MS T VA TS 
Mediastinoscopy 28/30 24/25 
Total number of nodes ampled 9.3 -+ 4.3 9.5 _+ 3.6 
for biopsy 
curative lobectomy was then performed by standard tho- 
racic surgical techniques. Complete mediastinal lymph 
node dissection was not performed in either of the two 
groups. 
Patients randomized to the VATS group had a lobec- 
tomy performed by means of techniques previously de- 
scribed, which included a6 to 8 cm "access" thoracotomy 
through which standard thoracic instruments were intro- 
duced without rib spreading, a°-12 Hilar dissection was 
performed in a manner similar to that used in the MST 
group w/th individual transection of the bronchovascular 
components. Mass stapling of the lobar hilum, the so- 
called SIS lobectomy, 17 was not performed. In each case 
the mediastinum was restaged thoracoscopically so that 
lobectomy represented a complete and potentially cura- 
tive resection. 
Results 
One patient in the MST group and two patients in 
the VATS group proved to have nonmalignant 
disease at the time of the operation and were 
therefore xcluded from the study (Fig. 1). Three 
additional patients in the VATS group required 
conversion to MST because of ditticulty in safely 
dissecting either the interlobar pulmonary artery or 
incomplete fissures and were therefore not included 
in the final analysis. This left a total of 30 patients in 
the MST group and 25 patients in the VATS group 
for comparison. Anatomic distribution of the pri- 
mary cancers and pathologic ell type are shown in 
Tables III and IV. 
No significant differences (p > 0.05) were de- 
tected between the MST and VATS groups in 
operative time (175 _+ 93 minutes versus 161 2 61 
minutes), intraoperative complications, or blood 
loss (Table V). In the MST group a bronchial tear 
occurred in one patient during dissection but was 
repaired without sequelae. Postoperatively there 
were again no significant differences (p > 0.05) 
between the two groups in duration of chest tube 
drainage or length of hospital stay (Table VI). The 
average duration of chest tube drainage was 6.5 -_ 
4.8 days for the MST group compared with 4.6 _+ 3.3 
days for the VATS group. Average duration of 
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61 Patients 
Stage h TIN0, T2N0 
31 S~T 3"~0 VATS 
I" disease non-malignant disease 2 non ma tgnant 
B 3 "con~erted" 
30 MST 25 ATS 
Fig. 1. Of 61 patients randomized, 6 were excluded from the study for the reasons hown, leaving 30 
patients in the MST group and 25 in the VATS group. 
Table ll I. Anatomic distribution of the primary 
cancers and lobectomies performed 
MST VATS 
Right upper lobe 7 6 
Right lower lobe 11 3 
Right middle lobe 1 5 
Left upper lobe 6 6 
Left lower lobe 5 5 
Table IV. Pathologic ell type in the two groups of 
patients 
MS T VA TS 
Squamous cell 11 9 
Adenocarcinoma 13 13 
Large cell 5 3 
Carcinoid 1 0 
hospital stay was 8.3 _+ 5.7 days for the MST group 
compared with 7.1 +_ 5.5 days for the VATS group. 
Significantly more postoperative complications oc- 
curred in the MST group than in the VATS group: 
sixteen versus six (p < 0.05). Prolonged air leak was 
defined as lasting longer than 7 days; it occurred in 
eight patients in the MST group and lasted an average 
of 10.8 +_ 3.2 days. Three patients in the VATS group 
had prolonged air leaks that lasted an average of 9.6 _+ 
1.1 days (no significant difference). The other compli- 
cations were a pulmonary embolism in a patient 
treated by VATS and Clostridium difficile colitis in a 
patient reated by MST. 
The clinical and pathologic stages of the two 
groups were compared. The stage of disease was 
reassessed as stage II (8 patients) or stage IIIA (3 
patients) in 11 of the 30 patients in the MST group. 
In 5 of the 25 (20%) patients in the VATS group the 
Table V. Comparison of operating room time, 
intraoperative complications and blood loss, costs, 
and the number of patients in the VATS lobectomy 
group who required MST 
MS T VA TS 
Operating room time (min) 175 ± 93 161 ± 61 
Converted to MST - -  3 
Intraoperative complications 1 0 
Blood loss 
<250 ml 25 21 
250-500 ml 2 4 
>500 ml 3 0 
Table VI. Comparison of the two groups in terms of 
length of chest ube drainage, length of hospital stay, 
and incidence of postthoracotomy pain 
MST VATS 
Chest tube drainage 6.5 ± 4.8 4.6 _+ 3.3 
(days) 
Length of hospital 8.3 ± 5.7 7.1 _+ 5.5 
stay (days) 
Postthoracotomy pain 2 1 
disease was restaged as either stage II (4 patients) or 
stage IIIA (1 patient). 
The average length of follow-up was 13 months 
with three patients dying: one at 6 months of a 
ruptured abdominal aortic aneurysm, one at 10 
months of cancer of the gallbladder, and one at 15 
months of metastatic lung cancer. The remaining 
patients remain alive and weil without evidence of 
recurrent disease. 
The overall incidence of disabling postthoracot- 
omy pain was again not significantly different be- 
tween the two groups (MST, n = 2; VATS, n = 1). 
The return to work time was not an accurate differ- 
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entiating factor between the two groups because the 
majority of patients were either not working or 
retired at the time of the operation. 
Discussion 
VATS represents an appealing new option for the 
management of many diseases that previously re- 
quired a thoracotomy. Advantages of VATS such as 
decreased pain, shortened hospital stay, and a faster 
return to work are offen presumed but, in most 
instances, await confirmation by elinical trials di- 
rectly comparing VATS to conventional teehniques. 
Even if such studies demonstrate hat VATS does 
indeed have initial short-term advantages, thoracie 
surgeons are still, in most instances, eoncerned with 
long-term control of the underlying disease and in 
particular with the loeal control and cure of cancer. 
Clearly there is a need to precisely define both the 
early advantages of VATS and its long-term equiv- 
alency to presently aceepted thoraeic procedures 
and survival figures. 
The effectiveness of thoracoscopy asa diagnostic 
tool in pleural and mediastinal diseases has been 
amply described. 1s-2° VATS need not replace simple 
optical thoracoscopy in the diagnosis and manage- 
ment of many benign and malignant diseases in- 
volving the pleura, mediastinum, or chest wall. In 
contrast o VATS, optical thoracoscopy is less in- 
vasive, necessitating one skin incision, and can often 
be performed with local anesthesia. Single lung 
ventilation is usually not required, and, in an era of 
cost containment, he fewer elaborate instruments 
makes it a more economical procedure. 
Because of the associated 10% false negative rate 
associated with mediastinoscopy in detecting the 
presence of N2 disease that is subsequently discov- 
ered at thoracotomy, consideration has been given 
to replacing mediastinoscopy with VATS as a stag- 
ing procedure for bronchogenic arcinoma. Sur- 
geons have argued that VATS will allow biopsy 
specimens to be obtained from areas that are inac- 
cessible to the mediastinoscope. Mediastinoscopy is 
a proved, safe, and reasonably accurate method for 
staging bronchogenic carcinoma. Data have not yet 
been presented comparing the sensitivity and overall 
accuracy of VATS to mediastinoscopy. VATS rep- 
resents a more invasive, complicated, and costly 
procedure than cervical mediastinoscopy, which is 
expeditiously performed through one incision with- 
out the need for single lung ventilation. To fully 
stage a patient's mediastinum by means of VATS 
requires multiple skin incisions, single lung ventila- 
tion, and a great deal more time and costly instru- 
mentation. That VATS may be a more sensitive and 
accurate staging procedure than mediastinoscopy 
remains to be demonstrated. 
Most thoracotomies are performed for malignant 
disease. In this study and in others, VATS lobec- 
tomy has been shown to be a safe and technically 
feasible operation in the setting of early stage I and 
II non-small-cell lung cancer. We have been unable 
to demonstrate significant short-term advantages of
VATS in terms of length of stay, return to work, or 
significantly decreased postoperative pain as com- 
pared with MST. Certainly the management of 
hemorrhage during any major pulmonary resection 
remains of concern, especially when the procedure 
is done in an essentially closed chest. Last, insutti- 
cient time has elapsed to report on the 5-year survival 
of patients after VATS lobectomy, the ultimate crite- 
tion in the management of lung cancer. 
This study is illustrative of the many controversies 
surrounding VATS proeedures in general. The po- 
tential short-term advantages of any VATS proce- 
dure should not be accepted as fact without further 
evidence. Mass stapling of the lobar bronchovascu- 
lar pedicle does not allow for the node dissection 
routinely performed during anatomic lobectomy 
and may adversely influence long-term survival. In 
the final analysis, potential short-term benefit or the 
surgeon's ability to perform a VATS procedure is of 
little value to the patients if the goal of long-term 
cure is compromised. 
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Discussion 
Dr. Joseph LoCicero III (Boston, Mass.). Dr. Kirby, 
thank you for updating the information you presented a 
year ago. Now you have a randomized series presenting 
some very detailed information. 
I would like to ask you specifically about your random- 
ization of patients. There are three centers involved in this 
randomized study and you have 55 patients. These are 
three very busy centers, and less than 60 patients in this 
report were actually randomized. These are fairly highly 
selected. Maybe you could give us more information about 
your selection criteria. 
Second, three patients in the VATS group were con- 
verted to MST. I assume these patients were randomized 
before they arrived in the operating room, or at the time 
of operation, to orte procedure or the other. Would it have 
made a difference had you randomized the patients after 
confirmation of your ability to perform a VATS proce- 
dure? 
Next, did your patients know what proeedure was going 
to be used before they were anesthetized? 
Dr. Kirby. Our selection criteria were strict, limiting 
potential study patients to those with clinical stage I 
non-small-cell lung eancer without any evidence of obvi- 
ous mediastinal adenopathy on computed tomographic 
scans of the chest. Despite patients being accrued from 
three large institutions, only 61 patients were ultimately 
entered over a 2-year period. All patients were informed 
that they would be randomized into either MST and 
lobectomy or VATS lobectomy. 
The fact that we excluded from analysis those patients 
who were converted from a VATS lobectomy to an MST 
does not alter our results in any way. In fact, excluding 
these patients whose operating room time was prolonged 
because two separate approaches were required would 
bias our study in favor of the VATS lobectomy group, if 
any bias occurred. 
Dr. Ralph J. Lewis (New Brunswick, N.J.). I would like 
to make a few comments on the randomized study. 
Aecording to some statisticians, when a randomized trial 
is used for a surgical procedure, results can vary because 
of an inherent subjectivity and inability to do a true double 
blind study, problems related to legal or ethical issues, 
patient cooperation, and even surgeons' kills and experi.- 
ence. And, of course, the irreversibility of the surgical 
procedure has a profound impact. 
Any of these factors can have a significant effect on the 
outcome. Actually the same randomized trial, when re- 
peated by different investigators, has given different re- 
sults. Some statisticians have argued that a valid random- 
ized trial should not and probably could not be done 
during the evolutionary phase of a Surgical procedure, 
when the skills, experience, techniques, philosophies, even 
surgical biases of the surgeons are constantly changing. 
I realize that the participants in this report are all very 
experienced and skillful VATS surgeons, but even they 
have minimal experience with VATS lobectomy when 
compared with their enormous kill and experience with 
open lobectomy. I think the numbers may be too small 
and it may be too early to try to draw definite conclusions. 
About 11/2 years ago I maintained that the technique 
developed for open lobeetomy was not suitable for VATS. 
I still believe that and I have abandoned the isolation 
ligation technique for VATS lobectomy. Thus I am pleas- 
antly surprised to hear that what I consider a suboptimal 
procedure, isolation ligation for VATS, with only meager 
experience on the part of the surgeons, seems to be 
holding its own against the vast experience you all have for 
open lobectomy. 
I have one other comment. I have not found the 
muscle-sparing incision to be helpful for my patients, but 
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I have found the bone-sparing incision of VATS to be very 
beneficial. 
I have just one question, Dr. Kirby. In the past you 
mentioned that you used a rib spreader on occasion when 
doing a VATS lobectomy. I am wondering il, in reality, 
you are comparing a true open lobectomy thoracotomy 
with a minithoracotomy lobectomy instead of a VATS 
lobectomy. 
Dr. Kirby. In terms of the validity of our study, we 
believed strongly that a randomized trial was scientifically 
the best method of demonstrating any advantages or 
disadvantages of these two surgical approaches. 
We believe strongly that out patients having VATS 
lobectomy were in no way comparable to those having 
MST in terms of the degree of rib spreading. In a VATS 
lobectomy each surgeon, to the best of his ability, avoided 
any spreading of the intercostal space until the end of the 
procedure and then only if it was necessary to remove the 
specimen. Eren in these instances preading of the inter- 
costal space was minimal and not comparable to the MST 
group. Some of the resections were actually completed 
entirely thoracoscopically with a minithoracotomy only 
being made at the end of the procedure to remove the 
specimen. 
Last, in terms of our operative technique, we abide by 
the time-honored technique of individual ligation and 
transection of the bronchovascular components. We do 
not believe in altering accepted and time-proven operative 
techniques imply to accommodate a surgical approach 
without further evidence of its safety or equivalence. Most 
surgeons in this audience would look aghast if at the time 
of a thoracotomy a large stapling device was simply placed 
across the hilum and fired. Unfortunately, mass stapling is 
an example of the end justifying the means. 
